Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anaxomics is a specialized bioinformatics and systems biology company that provides innovative solutions for drug discovery and clinical development. The company utilizes its proprietary Therapeutic Performance Mapping System (TPMS) technology to create mathematical models of biological processes, enabling the simulation of drug mechanisms of action and the identification of biomarkers. Anaxomics collaborates with pharmaceutical and biotech companies to optimize drug repositioning, predict potential side effects, and stratify patient populations for clinical trials. Their expertise spans across multiple therapeutic areas, including oncology, neurology, and rare diseases, helping to reduce risks and costs in the drug development lifecycle. By integrating artificial intelligence with biological networks, they provide high-level insights into complex disease pathologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anaxomics Biotech.